Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | H2AFJ |
| Upstream (Parents) |
|---|
| (<<) DPEP1 → H2AFJ |
| (<<) VAV3 → H2AFJ |
| (<<) SLC7A6 → H2AFJ |
| (<<) ATP9A → H2AFJ |
| (<<) ENGASE → H2AFJ |
| Downstream (Children) |
|---|
| H2AFJ → CRH (>>) |
| H2AFJ → L3MBTL (>>) |
| H2AFJ → DDX4 (>>) |
| H2AFJ → HCG4P6 (>>) |
| H2AFJ → BAGE (>>) |
| H2AFJ → ARID4B (>>) |
| H2AFJ → CBFA2T2 (>>) |
| H2AFJ → NKX3-1 (>>) |
| H2AFJ → FCHO2///GH1///CSH2///CSH1 (>>) |
| H2AFJ → ZNF493 (>>) |
